NRF2 activation by CDDO-Im regulates inflammatory and autophagy pathways in human microglial cells

Ching-Tung Chu1, Akira Uruno1, Takafumi Suzuki2

  • 1Department of Biochemistry and Molecular Biology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, 980-8573, Japan.

PubMed

Insights

Nuclear factor erythroid 2-related factor 2 (NRF2) activation in microglia reduces Alzheimer

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Alzheimer's disease (AD) pathology involves amyloid-beta plaques, neurofibrillary tangles, oxidative stress, and neuroinflammation.
  • Microglia, brain's immune cells, are crucial for clearing pathological aggregates and damaged neurons.
  • Nuclear factor erythroid 2-related factor 2 (NRF2) is a key regulator of cellular defense against oxidative stress, showing therapeutic potential in AD models.

Purpose of the Study:

  • To identify direct microglial targets of Nuclear factor erythroid 2-related factor 2 (NRF2).
  • To investigate the role of NRF2 activation in modulating microglial inflammation and autophagy.
  • To explore NRF2-mediated pathways as potential therapeutic targets for Alzheimer's disease.

Main Methods:

  • Utilized human microglial cells (HMC3) stimulated with Interferon-gamma (IFN-γ) or amyloid-beta (Aβ).
  • Activated NRF2 using CDDO-Im and analyzed gene expression via RNA-sequencing and NRF2 binding sites using ChIP-sequencing.
  • Assessed autophagy markers (LC3-II/LC3-I ratio) and analyzed public single-cell transcriptomic data from AD brains.

Main Results:

  • NRF2 activation significantly suppressed inflammation in HMC3 cells.
  • Identified direct NRF2 target genes involved in both inflammation (e.g., IL6, CDK6) and autophagy (e.g., TFE3, SQSTM1).
  • CDDO-Im treatment enhanced autophagy, and NRF2's role in autophagy regulation within AD microglia was confirmed.

Conclusions:

  • Revealed novel direct NRF2 target genes in microglia relevant to Alzheimer's disease.
  • Demonstrated NRF2's dual function in suppressing neuroinflammation and promoting autophagy.
  • These findings offer new therapeutic strategies targeting NRF2 pathways for Alzheimer's disease treatment.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K